China NMPA Inspection - Wuhan Haiandi Technology Co., Ltd. - April 07, 2016

A surprise inspection conducted by the National Medical Products Administration (NMPA) and documented on April 7, 2016, revealed critical issues at Wuhan Haiandi Technology Co., Ltd. The inspection found that the company's designated production facility no longer contained the necessary equipment or infrastructure for manufacturing medical devices. Consequently, the company was observed to be in a state of complete shutdown. In response to this non-compliance with regulatory standards, Wuhan Haiandi Technology Co., Ltd. is actively pursuing the cancellation of its medical device production license and all associated product registration certificates. The NMPA, operating under its regulatory framework, has directed the Hubei Provincial Food and Drug Administration to diligently monitor and confirm the progress and finalization of the company's license and product registration cancellation applications. This oversight ensures proper adherence to regulatory procedures even during a company's cessation of operations within the medical device sector.